Joseph Cheriyan
University of Cambridge(GB)Cambridge University Hospitals NHS Foundation Trust(GB)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Chronic Obstructive Pulmonary Disease (COPD) Research, Cardiovascular Health and Disease Prevention, Atherosclerosis and Cardiovascular Diseases, COVID-19 Clinical Research Studies
Most-Cited Works
- → Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis(2012)213 cited
- → Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor(2015)174 cited
- → Effects of p38 Mitogen-Activated Protein Kinase Inhibition on Vascular and Systemic Inflammation in Patients With Atherosclerosis(2012)152 cited
- → Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist(2015)152 cited
- → Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects(2019)142 cited
- → Effects of Oral Lycopene Supplementation on Vascular Function in Patients with Cardiovascular Disease and Healthy Volunteers: A Randomised Controlled Trial(2014)131 cited